公开(公告)号：EP0439453B1

公开(公告)日：1994-01-19

申请号：EP88908644.3

申请日：1988-09-29

申请人： Exomed Australia Pty. Ltd. (ACN 051 976 446) ,  Ostapat Pty. Ltd. (ACN 003 660 759) ,  Gastro Services Pty. Limited (ACN 002 994 890) ,  Capability Services Pty. Limited (ACN 003 015 227)

发明人： Exomed Australia Pty. Ltd. (ACN 051 976 446) ,  Ostapat Pty. Ltd. (ACN 003 660 759) ,  Gastro Services Pty. Limited (ACN 002 994 890) ,  Capability Services Pty. Limited (ACN 003 015 227)

IPC分类号： A61K33/24 ,  A61K31/29

CPC分类号： A61K31/70 ,  A61K33/245 ,  Y10S514/925 ,  A61K33/24 ,  A61K31/29 ,  A61K2300/00

摘要： The present invention provides a method for eradicating and/or preventing recurrence of gastrointestinal disorders associated with Campylobacter pylori infections, which involves the administration of a pharmaceutical composition, comprising a pharmaceutically acceptable bismuth compound with a first antibiotic and a second antibiotic. There is also provided a pharmaceutical composition for the treatment of gastrointestinal disorders associated with C. pylori, and pharmaceutical compositions for said treatment in the form of a sequential pack.